CClinicalTrials.gg
CompletedNCT03810274Updated Jan 18, 2019

3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

An observational study in Radiotherapy and Nasopharyngeal Carcinoma, sponsored by Xinqiao Hospital of Chongqing. Completed at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-01-18.

Sponsored by Xinqiao Hospital of Chongqing · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
300
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Comparing the accuracy and speed of 3DV+TPS software with imported TPS and domestic TPS to outline the contours of crisis organs, it is proved that 3DV+TPS has superiority compared with domestic TPS, and it has non-inferiority compared with imported TPS, indicating that the software can improve contour sketching accuracy. And speed, reduce the burden on doctors, improve medical efficiency.

Read the detailed description

Comparing the accuracy and speed difference between 3DV+TPS software and imported TPS and domestic TPS to outline the contours of crisis organs, the selected organs are: bilateral eyeballs, bilateral crystals, bilateral optic nerves, bilateral parotid glands, oral cavity, spinal cord, brainstem, The brain has a total of 12 organs; verify that 3DV+TPS is superior to domestic TPS, and has non-inferiority compared with imported TPS, Ming software can improve the accuracy and speed of contour sketching, reduce the burden on doctors, and improve medical efficiency.

02

Conditions studied

  • Radiotherapy
  • Nasopharyngeal Carcinoma
03

In context

Carcinoma

6,741 studies on the registry are indexed under Carcinoma; 1,161 are open to participants now.

This study's enrollment of 300 is above the median of 149 across 1,175 observational studies indexed under Carcinoma.

Browse Carcinoma studies →

Lead sponsor

Xinqiao Hospital of Chongqing is the lead sponsor of 68 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A total of 7 different grade hospital radiotherapy centers have received radiotherapy for patients with nasopharyngeal carcinoma Case information, based on inclusion and exclusion criteria, a total of 300 cases were screened. Among them, Xinqiao Hospital collected 180 cases, He collected 20 cases in 20 hospitals, totaling 200 cases.

Inclusion criteria

  1. It is diagnosed as nasopharyngeal carcinoma by histopathological examination, and there is no tumor invasion in the organs that need to be assessed;
  2. Age 18-70 years old;
  3. There is nasopharynx localization enhanced CT, nasopharynx enhanced MRI.

Exclusion criteria

Exclusion Criteria:

  1. Patient information is incomplete; no age, gender, MRI, height, radiotherapy location CT;
  2. The organs at risk that need to be assessed are invaded by the tumor;
  3. Any reason cannot be combined with the research or the researcher believes that it is not suitable for inclusion in this test.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
300 participants (actual)
Patient registry
No

Groups and cohorts

  • 3DV+TPS

    This experiment included a total of 300 patients with nasopharyngeal carcinoma, using 3DV + TPS software and imported TPS, domestic TPS, these three sets of TPS delineate bilateral crystal, bilateral optic nerve, bilateral eyeball, bilateral parotid gland, oral cavity, spinal cord There are 12 organs in the brainstem and brain, and the accuracy and speed of the 3 sets of TPS sketches are compared.

    Device: 3DV+TPS;VARIAN TPS;FonicsPlan

Interventions

  • Device3DV+TPS;VARIAN TPS;FonicsPlan
06

What researchers measure

Primary outcomes

  1. Sketching accuracy

    Define ΔV as a percentage of the total volume of the gold standard;

    Time frame: one year

  2. Sketch speed

    Use the stopwatch to record the total time used to draw down 12 organs, to start sketching as the starting point of the time, and to finish the saving of the data.

    Time frame: one year

07

Study locations

1 site
  • Xinqiao Hospital of Chongqing
    Chongqing, 400000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03810274
Lead sponsor
Xinqiao Hospital of Chongqing
Responsible party
Jianguo Sun (Deputy Director, Xinqiao Hospital of Chongqing) — Principal investigator
First posted
Jan 18, 2019
Start date
Feb 1, 2012
Primary completion
Dec 31, 2018
Completion
Jan 15, 2019
Last update
Jan 18, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion